Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat

Carcinogenesis

Volumn 24, Issue 3, 2003, Pages 573-582

  Habib, Samy L ^a   Phan, Minh N ^a   Patel, Sonal K ^a   Li, Donghui ^b   Monks, Terrence J ^a   Lau, Serrine S ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; ACUTE PHASE PROTEIN; DNA; DNA GLYCOSYLTRANSFERASE; GLUTATHIONE DERIVATIVE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYDROQUINONE DERIVATIVE; RAP PROTEIN; TUBERIN; TUMOR SUPPRESSOR PROTEIN;

ACUTE PHASE RESPONSE; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA DAMAGE; EXPOSURE; GENE MUTATION; GENETIC CODE; KIDNEY CANCER; KIDNEY MEDULLA; KIDNEY TUMOR; NEPHROTOXICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT STRAIN; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE; WILD TYPE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA DAMAGE; DNA-FORMAMIDOPYRIMIDINE GLYCOSYLASE; ELECTROCHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE; HYDROQUINONES; KIDNEY; MALE; N-GLYCOSYL HYDROLASES; OXIDATIVE STRESS; RATS; RATS, MUTANT STRAINS; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0037360062     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/24.3.573     Document Type: Review

References (58)

1. Wienecke,R., Konig,A. and DeClue,J.E. (1995) Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J. Biol. Chem., 270, 16409-16414.
2. Nishio,K., Fukuoka,K., Fukumoto,H., Sunami,T., Iwamoto,Y., Suzuki,T., Usuda,J. and Saijo,N. (1999) Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells. Int. J. Oncol., 14, 461-469.
3. York,R.D., Yao,H., Dillon,T., Ellig,C.L., Eckert,S.P., McCleskey,E.W. and Stork,P.J. (1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature, 392, 622-626.
4. Yoshida,Y., Kawata,M., Miura,Y., Musha,T., Sasaki,T., Kikuchi,A. and Takai,Y. (1992) Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol. Cell Biol., 12, 3407-3414.
5. Rubinfeld,B., Munemitsu,S., Clark,R., Conroy,L., Watt,K., Crosier,W.J., McCormick,F. and Polakis,P. (1991) Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1. Cell, 65, 1033-1042.
6. Soucek,T., Pusch,O., Wienecke,R., DeClue,J.E. and Hengstschlager,M. (1997) Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J. Biol. Chem., 272, 29301-29308.
7. Catania,M.G., Mischel,P.S. and Vinters,H.V. (2001) Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B. J. Neuropathol. Exp. Neurol., 60, 711-723.
8. Schmitt,J.M. and Stork,P.J. (2001) Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1. Mol. Cell Biol., 21, 3671-3683.
9. Yoon,H.S., Monks,T.J., Everitt,J.I., Walker,C.L. and Lau,S.S. (2002) Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity. Am. J. Physiol. Renal Physiol., 283, F262-F270.
10. Yoon,H.S., Ramachandiran,S., Monks,T.J. and Lau,S.S. (2002) The tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells. Mol. Pharm. (submitted).
11. Henry,K.W., Yuan,X., Koszewski,N.J., Onda,H., Kwiatkowski,D.J. and Noonan,D.J. (1998) Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J. Biol. Chem., 273, 20535-20539.
12. Wienecke,R., Maize,J.C., Jr., Shoarinejad,F., et al. (1996) Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene, 13, 913-923.
13. Xiao,G.H., Shoarinejad,F., Jin,F., Golemis,E.A. and Yeung,R.S. (1997) The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J. Biol. Chem., 272, 6097-6100.
14. Plank,T.L., Yeung,R.S. and Henske,E.P. (1998) Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res., 58, 4766-4770.
15. Aicher,L.D., Campbell,J.S. and Yeung,R.S. (2001) Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. J. Biol. Chem., 276, 21017-21021.
16. Eker,R. and Mossige,J. (1961) A dominant gene for renal adenomas in the rat. Nature, 189, 858-859.
17. Kobayashi,T., Hirayama,Y., Kobayashi,E., Kubo,Y. and Hino,O. (1995) A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat. Genet., 9, 70-74.
18. Yeung,R.S., Buetow,K.H., Testa,J.R. and Knudson,A.G.,Jr. (1993) Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc. Natl Acad. Sci. USA, 90, 8038-8042.
19. Everitt,J.I., Goldsworthy,T.L., Wolf,D.C. and Walker,C.L. (1992) Hereditary renal cell carcinoma in the Eker rat: a rodent familial cancer syndrome. J. Urol., 148, 1932-1936.
20. Walker,C., Goldsworthy,T.L., Wolf,D.C. and Everitt,J. (1992) Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. Science, 255, 1693-1695.
21. Yeung,R.S., Xiao,G.H., Jin,F., Lee,W.C., Testa,J.R. and Knudson,A.G. (1994) Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc. Natl Acad. Sci. USA, 91, 11413-11416.
22. Hino,O., Kobayashi,E., Hirayama,Y., Kobayashi,T., Kubo,Y., Tsuchiya,H., Kikuchi,Y. and Mitani,H. (1995) Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (TSC2). Mol. Carcinog., 14, 23-27.
23. Peters,M.M., Jones,T.W., Monks,T.J. and Lau,S.S. (1997) Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glutathion-S-yl)hydroquinone. Carcinogenesis, 18, 2393-2401.
24. Lau,S.S., Monks,T.J., Everitt,J.I., Kleymenova,E. and Walker,C.L. (2001) Carcinogenicity of a nephrotoxic metabolite of the 'nongenotoxic' carcinogen hydroquinone. Chem. Res. Toxicol., 14, 25-33.
25. Jeong,J.K., Wogan,G.N., Lau,S.S. and Monks,T.J. (1999) Quinolglutathione conjugate-induced mutation spectra in the supF gene replicated in human AD293 cells and bacterial MBL50 cells. Cancer Res., 59, 3641-3645.
26. Yoon,H.S., Monks,T.J., Walker,C.L., Lau,S.S. (2001) Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene. Mol. Carcinog., 31, 37-45.
27. Towndrow,K.M., Mertens,J.J., Jeong,J.K., Weber,T.J., Monks,T.J. and Lau,S.S. (2000) Stress- and growth-related gene expression are independent of chemical-induced prostaglandin E (2) synthesis in renal epithelial cells. Chem. Res. Toxicol., 13, 111-117.
28. Fearon,E.R. (1997) Human cancer syndromes: clues to the origin and nature of cancer. Science 278, 1043-1050.
29. Weitzman,S.A. and Gordon,L.I. (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood, 76, 655-663.
30. McBride,T.J., Preston,B.D. and Loeb,L.A. (1991) Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry, 30, 207-213.
31. Moriya,M., Ou,C., Bodepudi,V., Johnoson,F., Takeshita,M. and Grollman,A.P. (1991) Site-specific mutagenesis using a gapped duplex vector: a study of translesion synthesis past 8-oxodeoxyguanosine in E.coli. Mutat. Res., 254, 281-288.
32. Feig,D.I., Sowers,L.C. and Loeb,L.A. (1994) Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA. Proc. Natl Acad. Sci. USA, 91, 6609-6613.
33. Maccabee,M., Evans,J.S., Glackin,M.P., Hatahet,Z. and Wallace,S.S. (1994) Pyrimidine ring fragmentation products. Effects of lesion structure and sequence context on mutagenesis. J. Mol. Biol., 236, 514-530.
34. Kasai,H. and Nishimura,S. (1993) Formation of 8-hydroxyguanine by oxidative DNA damage, its repair and its mutagenic effects. In de Obe,G. (ed.) Advances in Mutagenesis Research. Springer-Verlag, Berlin, Vol. 4, pp. 31-45.
35. Umemura,T., Sai,K., Takagi,A., Hasegawa,R. and Kurokawa,Y. (1990) Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis, 11, 345-347.
36. Cheng,K.C., Cahill,D.S., Kasai,H., Nishimura,S. and Loeb,L.A. (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G→T and A→C substitutions. J. Biol. Chem., 267, 166-172.
37. Nash,H.M., Bruner,S.D., Schärer,O.D., Kawate,T., Addona,T.A., Spooner,E., Lane,W.S. and Verdine,G.L. (1996) Cloning of a yeast 8-oxoguanine DNA glycosylase reveals the existence of a base-excision DNA-repair protein superfamily. Current Biol., 6, 968-980.
38. Klungland,A., Rosewell,I., Hollenbach,S., Larsen,E., Daly,G., Epe,B., Seeberg,E., Lindahl,T. and Barnes,D.E. (1999) Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl Acad. Sci. USA, 96, 13300-13305.
39. Audebert,M., Chevillard,S., Levalois,C., et al. (2000) Alterations of DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res., 60, 4740-4744.
40. Lau,S.S., Hill,B.A., Highet,R.J., Monks,T.J. (1988) Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol. Pharmacol., 34, 829-836.
41. Habig,W.H., Pabst,M.J. and Jakoby,W.B. (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
42. Laws,G.M. and Adams,S.P. (1996) Measurement of 8-OHdG in DNA by HPLC/ECD: the importance of DNA purity. Biotechniques, 20, 36-38.
43. Li,D., Zhang,W., Li,D., Zhang,W., et al. (2001) Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol. Carcinog., 31, 214-223.
44. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
45. Hazra,T.K., Izumi,T., Maidt,L., Floyd,R.A. and Mitra,S. (1998) The presence of two distinct 8-oxoguanine repair enzymes in human cells: their potential complementary roles in preventing mutation. Nucleic Acids Res., 26, 5116-5122.
46. Lau,S.S., Peters,M.M., Kleiner,H.E., Canales,P.L. and Monks,T.J. (1996) Linking the metabolism of hydroquinone to its nephrotoxicity and nephrocarcinogenicity. Adv. Exp. Med. Biol., 387, 267-273.
47. Jaiswal,M., LaRusso,N.F., Nishioka,N., Nakabeppu,Y. and Gores,G.J. (2001) Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res., 61, 6388-6393.
48. Hodges,N.J. and Chipman,J.K. (2002) Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells. Carcinogenesis, 23, 55-60.
49. The European Chromosome 16 Tuberous Sclerosis Consortium. (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 75, 1305-1315.
50. Arai,K., Morishita,K., Shinmura,K., Kohno,T., Kim,S.R., Nohmi,T., Taniwaki,M., Ohwada,S. and Yokota,J. (1997) Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene, 14, 2857-2861.
51. Masuda,K., Miyamoto,T., Jung,C.G., Ding,M., Cheng,J.M., Tsumagari,T., Manabe,T. and Agui,T. (2001) Linkage mapping of the rat 8-oxoguanine DNA glycosylase gene to chromosome 4. Exp. Anim., 50, 353-354.
52. Lou,D., Griffith,N. and Noonan,D.J. (2001) The tuberous sclerosis 2 gene product can localize to nuclei in a phosphorylation-dependent manner. Mol. Cell Biol. Res. Commun., 4, 374-380.
53. Lin,L.H., Cao,S., Yu,L., Cui,J., Hamilton,W.J. and Liu,P.K. (2000) Up-regulation of base excision repair activity for 8-hydroxy-2′-deoxyguanosine in the mouse brain after forebrain ischemia-reperfusion. J. Neurochem., 74, 1098-1105.
54. Hollenbach,S., Dhenaut,A., Eckert,I., Radicella,J.P. and Epe,B. (1999) Overexpression of Ogg1 in mammalian cells: effects on induced and spontaneous oxidative DNA damage and mutagenesis. Carcinogenesis, 20, 1863-1868.
55. Chevillard,S., Radicella,J.P., Levalois,C., Lebeau,J., Poupon,M.F., Oudard,S., Dutrillaux,B. and Boiteux,S. (1998) Mutations in OGG1, a gene involved in the repair of oxidative DNA damage, are found in human lung and kidney tumours. Oncogene, 16, 3083-3086.
56. Audebert,M., Chevillard,S., Levalois,C., et al. (2000) Alterations of the DNA repair gene OGG1 in human clear cell carcinomas of the kidney. Cancer Res., 60, 4740-4744.
57. Hill,B.A., Davison,K.L., Dulik,D.M., Monks,T.J. and Lau,S.S. (1994) Metabolism of 2- (glutathion-S-yl)hydroquinone and 2,3,5- (triglutathion-S-yl)hydroquinone in the in situ perfused rat kidney: relationship to nephrotoxicity. Toxicol. Appl. Pharmacol., 129, 121-132.
58. Kleiner,H.E., Jones,T.W., Monks,T.J. and Lau,S.S. (1998) Immunochemical analysis of quinol-thioether-derived covalent protein adducts in rodent species sensitive and resistant to quinol-thioether-mediated nephrotoxicity. Chem. Res. Toxicol., 11, 1291-1300.